Dexter Surgical Robot: Distalmotion Advances with Milestones
Distalmotion, a MedTech company specializing in robotic surgery, has completed clinical trials for cholecystectomy and benign hysterectomy in the...
AP Biosciences Doses First Patient in AP402 Phase 1/2 Trials
AP Biosciences has dosed the first patient in a Phase 1 trial of AP402, a novel T cell engager...
March Biosciences MB-105 Dosed in First T-Cell Lymphoma Patient
March Biosciences has dosed the first patient in a Phase 2 clinical trial for MB-105, a CD5-targeted CAR-T cell...
Kymera Doses First Patient in KT-621 Atopic Dermatitis Trial
Kymera Therapeutics has initiated its BroADen Phase 1b clinical trial for KT-621, an oral STAT6 degrader, in patients with...
Argentina Fines Ferring: Privacy Wake-Up Call for Pharma
In a precedent-setting decision, Argentina’s Data Protection Authority (Agencia de Acceso a la Información Pública – AAIP) has fined...
How Cybin is Shifting Psychedelic Clinical Trial Execution and Regulatory Strategy
In the dynamic field of mental health, Cybin is pioneering psychedelic therapies. Amir Inamdar, Cybin’s Chief Medical Officer, discusses...
Savolitinib Shows Promise in Gastric Cancer: Phase II Trial Completed
HUTCHMED has completed enrollment for the registration phase of its Phase II savolitinib trial in gastric cancer patients with...
GeneSight Test Reduces Psychiatric Hospitalizations in Depression Patients
A study published in the Journal of Clinical Psychopharmacology revealed that patients with major depressive disorder experienced fewer psychiatric...
Achieve Life Sciences Publishes Smoking Cessation Trial Results in JAMA
Achieve Life Sciences announced complete results from its ORCA-3 trial, published in JAMA Internal Medicine, demonstrating cytisinicline’s efficacy in...
FDA Grants Orphan Drug Designation to TPST-1495 for FAP Treatment
Tempest Therapeutics announced that the FDA granted Orphan Drug Designation to TPST-1495 for treating Familial Adenomatous Polyposis (FAP). TPST-1495...